Page last updated: 2024-10-25

cimetidine and Axonotmesis

cimetidine has been researched along with Axonotmesis in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatton, J1
Lu, WY1
Rhoney, DH1
Tibbs, PA1
Dempsey, RJ1
Young, B1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit[NCT00633035]Phase 460 participants (Actual)Interventional2007-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for cimetidine and Axonotmesis

ArticleYear
A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit.
    Surgical neurology, 1996, Volume: 46, Issue:5

    Topics: Adult; Cimetidine; Clinical Protocols; Critical Care; Drug Therapy, Combination; Gastric Acid; Gastr

1996